https://www.selleckchem.com/pr....oducts/napabucasin.h
This vaccine candidate BBV152 has completed Phase I/II (NCT04471519) clinical trials in India and is presently in phase III, data of this study substantiates the immunogenicity and protective efficacy of the vaccine candidates.Reaction-induced porosity is a key factor enabling protracted fluid-rock interactions in the Earth's crust, promoting large-scale mineralogical changes during diagenesis, metamorphism, and ore formation. Here, we show experimentally that the presence of trace amounts of dissolved cerium increases the porosity
Like
Comment
Share
